Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

NNC0537-1482

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · PHASE 1 TRIAL

A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

ClinicalTrials.gov

Phase 1 safety and tolerability study in a planned enrollment of 36 participants; no results are yet reported in this registry record.

PreliminaryNCT07218627 Heart Failure Novo Nordisk

Reported

Planned enrollment36

PhasePHASE 1

Primary outcome measureNumber of treatment emergent adverse events…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support